Literature DB >> 15992701

New insights on cell death from radiation exposure.

Kevin M Prise1, Giuseppe Schettino, Melvyn Folkard, Kathryn D Held.   

Abstract

Ionising radiation has been an important part of cancer treatment for almost a century, being used in external-beam radiotherapy, brachytherapy, and targeted radionuclide therapy. At the molecular and cellular level, cell killing has been attributed to deposition of energy from the radiation in the DNA within the nucleus, with production of DNA double-strand breaks playing a central part. However, this DNA-centric model has been questioned because cell-death pathways, in which direct relations between cell killing and DNA damage diverge, have been reported. These pathways include membrane-dependent signalling pathways and bystander responses (when cells respond not to direct radiation exposure but to the irradiation of their neighbouring cells). New insights into mechanisms of these responses coupled with technological advances in targeting of cells in experimental systems with microbeams have led to a reassessment of the model of how cells are killed by ionising radiation. This review provides an update on these mechanisms.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2005        PMID: 15992701     DOI: 10.1016/S1470-2045(05)70246-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  92 in total

1.  Dose enhancement effects to the nucleus and mitochondria from gold nanoparticles in the cytosol.

Authors:  A L McNamara; W W Y Kam; N Scales; S J McMahon; J W Bennett; H L Byrne; J Schuemann; H Paganetti; R Banati; Z Kuncic
Journal:  Phys Med Biol       Date:  2016-07-20       Impact factor: 3.609

Review 2.  Clinical radioimmunotherapy--the role of radiobiology.

Authors:  Jean-Pierre Pouget; Isabelle Navarro-Teulon; Manuel Bardiès; Nicolas Chouin; Guillaume Cartron; André Pèlegrin; David Azria
Journal:  Nat Rev Clin Oncol       Date:  2011-11-08       Impact factor: 66.675

3.  Cardioprotective effect of zingerone against oxidative stress, inflammation, and apoptosis induced by cisplatin or gamma radiation in rats.

Authors:  Ahmed F Soliman; Lobna M Anees; Doaa M Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-07       Impact factor: 3.000

4.  Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies.

Authors:  Suneil Jain; Jonathan A Coulter; Alan R Hounsell; Karl T Butterworth; Stephen J McMahon; Wendy B Hyland; Mark F Muir; Glenn R Dickson; Kevin M Prise; Fred J Currell; Joe M O'Sullivan; David G Hirst
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-11-20       Impact factor: 7.038

5.  LNT: a never-ending story.

Authors:  Anna A Friedl; Werner Rühm
Journal:  Radiat Environ Biophys       Date:  2006-03       Impact factor: 1.925

6.  Protective bystander effects simulated with the state-vector model.

Authors:  Helmut Schöllnberger; Peter M Eckl
Journal:  Dose Response       Date:  2007-06-26       Impact factor: 2.658

7.  New challenges in radiobiology research with microbeams.

Authors:  Marco Durante; Anna A Friedl
Journal:  Radiat Environ Biophys       Date:  2011-06-12       Impact factor: 1.925

8.  Genomic instability after targeted irradiation of human lymphocytes: evidence for inter-individual differences under bystander conditions.

Authors:  Munira A Kadhim; Ryonfa Lee; Stephen R Moore; Denise A Macdonald; Kim L Chapman; Gaurang Patel; Kevin M Prise
Journal:  Mutat Res       Date:  2010-03-27       Impact factor: 2.433

Review 9.  Gold nanoparticles in breast cancer treatment: promise and potential pitfalls.

Authors:  Jihyoun Lee; Dev Kumar Chatterjee; Min Hyuk Lee; Sunil Krishnan
Journal:  Cancer Lett       Date:  2014-02-17       Impact factor: 8.679

10.  Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumors.

Authors:  Daniel Y Joh; Gary D Kao; Surya Murty; Melissa Stangl; Lova Sun; Ajlan Al Zaki; Xiangsheng Xu; Stephen M Hahn; Andrew Tsourkas; Jay F Dorsey
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.